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Abstract DsbA possesses a redox active disulphide, with the 
equilibrium strongly shifted towards the reduced form as 
compared to its structural homologue, thioredoxin. It is widely 
believed that the two amino acids that separate the active site 
cysteines play a crucial role in determining oxidising power 
within the thioredoxin family. Data concerning redox and pK, 
properties for DsbA mutants in this region are available. 
Electrostatics calculations show reasonable agreement with the 
experimental data, and support the suggestion that amino acids 
outside of the CXXC active site sequence are as important in 
determining oxidising power within the thioredoxin family as are 
those within it. 
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1. Introduction 
DsbA is a periplasmic protein that catalyses the introduc- 
tion of disulphide bonds [1,2]. The structure of the Escherichia 
coli enzyme, solved at 2 A resolution [3], shows a thioredoxin- 
like domain plus a 76 residue insert that forms a predomi- 
nantly a-helical domain. The region containing the active site 
disulphide superimposes almost precisely onto the homolo- 
gous region of the I .7 A crystal structure of E. coli thioredox- 
in [4]. Whereas DsbA acts to make disulphide bonds, thio- 
redoxin reduces them. This functional difference is reflected in 
the large separation in standard redox potentials, which are 
about -260 mV for thioredoxin and -100 mV for DsbA [5]. 
Establishing the molecular basis for these differences, in the 
context of homologous structures, has presented a challenge 
for experiment and theory. Since DsbA lies at the oxidising 
end of the thioredoxin family spectrum, this challenge is often 
stated as a search for the basis of the oxidising power of 
DsbA. 
Experimental studies have gone a long way towards ex- 
plaining the oxidising power of DsbA in terms of the sta- 
bilities of reduced and oxidised forms, and with reference to 
the pK, of the active site thiolate (C30). It has been found 
that the reduced form is favoured by 16 to 22 kJ/mol over the 
disulphided form [6,7]. The pK, of C30 in DsbA is about 3.5 
[8], as compared to that of 6.7 for the homologous thiolate 
(C32) in thioredoxin [9]. It has been suggested that the oxidis- 
ing power of DsbA could originate from the low C30 pK,, 
through stabilisation of the reduced form [8]. The link be- 
tween DsbA stability in reduced and oxidised forms, C30 
pK, (reduced form), and redox potential has been further 
investigated [lo]. These properties were measured for DsbA 
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mutants and wild-type (wt), and it was found that changes in 
C30 pK, correlate closely with alterations in the relative sta- 
bility of reduced and oxidised forms, and with redox poten- 
tial. The mutations were contained within the two amino acids 
that separate the active site cysteines. Since protein properties 
vary significantly with changes in these two residues, it was 
concluded that they are critical in determining the oxidising 
power of DsbA [lo]. Sub-groups within the thioredoxin family 
are characterised by the nature of these two residues, which 
are PH in DsbA and normally GP in thioredoxin. In compar- 
ison to the ApK, between homologous thiolates in DsbA and 
thioredoxin of 3.2, the range of ApK, between wt and mutant 
is 0.881.4 for all mutants other than PP, for which ApK, = 3.3 
UOI. 
Modelling has also been used to study the oxidising power 
of DsbA. Finite difference (FD) electrostatics calculations 
have been used to study the ApK, between C30 of DsbA 
and C32 of thioredoxin [l I]. Such a difference calculation 
between structurally homologous systems is well suited to 
these methods, which solve the Poisson-Boltzmann (PB) equa- 
tion. Based on obtaining a reasonable match between calcu- 
lated and experimental C3O/C32 ApK,‘s, the calculations were 
analysed to give a molecular model for the difference in oxi- 
dising power between DsbA and thioredoxin. It was suggested 
that the identity of the two amino acids between the active site 
cysteines plays a role, along with the presence of the extra 
domain in DsbA, and differences in mainchain conformation 
within the common (thioredoxin-like) domain. These calcula- 
tions suggest that differential stabilisation of a functionally 
homologous thiolate can be achieved in a variety of ways, 
not all of which are as clear-cut as sequence variation within 
two amino acids. 
This article presents electrostatics calculations to compare 
with the experimental data for DsbA mutants other than PP 
[lo]. The agreement with experiment is discussed in terms of 
both the molecular basis of the oxidising power of DsbA, and 
the limits of such calculations in relation to conformational 
alterations. It will be argued that the PP mutant cannot adopt 
the same active site structure in detail as that common to 
E. coli thioredoxin and E. coli DsbA, so that its properties 
represent a deviation from the redox spectrum that links these 
two proteins. Elements which contribute significantly to this 
spectrum, and which lie outside of the active site sequence, are 
discussed. 
2. Methods 
2.1. DsbA wt and mutant structures 
The basis for modelling with DsbA is the X-ray structure of the 
oxidised molecule at 2 A resolution 131. A model for the reduced 
structure has been used previously, based on breaking the disulphide 
(C3&C33) and torsioning C30 to maintain van der Waals (VdW) 
contact with C33 [ll]. The calculated electrostatic stabilisation of 
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the negatively charged C30 thiolate was found to be relatively insen- 
sitive to torsioning of the cysteine sidechain within the steric con- 
straints of the surrounding protein. DsbA mutants involving the res- 
idues that lie between C30 and C33 have been constructed, and their 
pK,‘s measured [lo], (J. Bardwell, personal communication). These 
were modelled with the program QUANTA (Molecular Simulations 
Inc., 200 Fifth Avenue, Waltham, MA 02154, USA). Sidechains were 
rotated to avoid steric clashes, and ApK,‘s were calculated as differ- 
ences between wt and mutants, using previously described procedures 
[ll]. All mutants other than PP could be accommodated without 
movement of the surrounding protein. The double proline mutant 
would require significant mainchain rearrangement, as the wt back- 
bone torsion angles are not consistent with such a sequence. Since the 
modelling is based on homology to wt, without mainchain movement, 
the PP mutant has not been included in the comparison. 
2.2. Electrostatics calculations 
Computational analysis used FD solutions to the PB equation 
[12,13], implemented in the program FDCALC. A value of 3 was 
used for the protein relative dielectric (E?), within the normally ac- 
cepted range of 24 [14]. Some calculatrons were carried out with 
Ed = 20, to test the suggestion that higher Ed may be more appropriate 
[15]. A solvent relative dielectric (~5) of 80, and a linear ion response 
for 0.15 M univalent ions were used in the FD calculations. Calcu- 
lated results vary by only about 1% when the ionic strength is altered 
from 0.15 M to 0.2 M, which corresponds to experiment [lo]. Partial 
charges were allocated from the GROMOS library [16]. Ionisable 
group charges are assigned to ODl and 0D2 of aspartic acid. to 
OEl and OE2 of glutamic acid, to ND1 and NE2 of histidine, to 
NH1 and NH2 of arginine, to NZ of lysine, to the nitrogen of N- 
terminal groups, and to the oxygens of C-terminal groups. Estimates 
of the dependence on charge and atomic radii were made with the use 
of an alternative partial charge set from QUANTAICHARMm, and 
through also using 2 VdW radii sets [17,18]. 
In pK, calculations, the three electrostatic contributions ASE (self- 
energy), ADIP (fixed dipolar charges) and AIONIS (ionisable groups) 
are calculated for the change in ionisable group charge interactions 
that accompanies the transfer from free amino acid to protein. These 
calculations are not consistently accurate [15,19], and much of the 
problem appears to be associated with ionisable group solvent acces- 
sibility (SA) changes on transfer to the protein (unpublished work). 
Such calculations for the DsbA system are also likely to be compli- 
cated by a pH-dependent conformational change, by analogy with 
that involving homologous groups in thioredoxin [20]. In order to 
calculate ApK,‘s to compare with experiment, the differences between 
wt and mutant are considered directly, rather than proceeding 
through the free C30 amino acid step (which cancels). For simplicity, 
the calculated contributions to ApK, are considered as single differ- 
ences, ASE, ADIP and AIONIS (taken directly between wt and mu- 
tant). By comparison with pK, calculations, these ApK,‘s are derived 
for very small changes in SA, and this is a key factor in providing 
more accuracy than is generally associated with pK, computations. In 
place of a titration curve calculation, AIONIS is calculated with an 
assumed set of ionisable group charge states in the acidic range of the 
measured pK,‘s. Following previous work [11], the only deviations 
from model pK,‘s are assumed for H60, which is taken to be neutral 
based on hydrogen bonding in the crystal structure, and for E24, 
which is assumed to be one half negatively charged. Lysines, arginines 
and histidines (except H60) have a charge of +l, whilst aspartic and 
glutamic acids (other than E24) have a charge of - 1. Excepting the 
contribution of H32, AIONIS is small, and does not contribute sig- 
nificantly to the ApK, values. 
3. Results and discussion 
3.1. pK, changes in DsbA mutants 
Table 1 shows experimental [lo], (J. Bardwell, persona1 
communication), and calculated ApK,‘s for 8 mutants of 
DsbA with amino acid changes at residues 31 and 32, with 
the PP mutant excluded from this comparison which is based 
on conserved mainchain structure. For calculations with the 
GROMOS partial charge set and the first VdW radii set [17], 
5 out of 8 calculated values match the measurements, within 
experimental error. Calculations with the QUANTA! 
CHARMm partial charge set, for which 5 out of 8 again 
match within experimental error, differ mostly for those mu- 
tants where P31 is altered. Changing a proline to a non-pro- 
line residue involves a larger alteration in partial charges for 
the GROMOS set than for the QUANTA/CHARMm set, 
with the result that the ApK,‘s for such a mutation tend to 
be larger for GROMOS partial charges. For the mutants 
which agree well with experiment, the GROMOS and QUAN- 
TA/CHARMm charge set values tend to surround the experi- 
mental values, and it is not possible to determine a preference. 
Changing to the second VdW radii set [18] shows a variation 
of up to 15% in ApK, (calculations not shown). Clearly the 
detailed results depend on the choice of partial charge and 
VdW radii sets. The degree of error associated with this choice 
is just fractions of a pK, unit for the DsbA mutants, and does 
not obscure the overall success of the dielectric continuum 
mode1 in giving the direction and overall size of the set of 
ApK,‘s. 
Another source of model error arises from the use of just 
one modelled conformation for each mutant. A small degree 
of variation with sidechain rotamer choice was found, and it is 
unlikely that better agreement with experiment (for most of 
the mutants in Table 1) could reasonably be expected without 
a substantially improved algorithm for including conforma- 
tional heterogeneity. The worst agreement is found for the 
TR mutant. The arginine sidechain was modelled as predomi- 
nantly extended, and it is possible that failure to include hy- 
drophobic packing against the protein could have contributed 
to this error. Discrepancies of less than half a pK, unit are 
comparable to thermal energy at physiological temperatures, 
giving another indication that more accurate modelling will 
require sensitive techniques for handling conformational var- 
iation. 
Whilst the ranking of mutants within this relatively small 
range of ApK,‘s is not well reproduced, it is possible to in- 
vestigate the molecular basis for the overall sign and size of 
the ApK,‘s. Table 2 shows the ApK,‘s calculated with the 
GROMOS partial charge set, along with the major contribu- 
tions. These are the removal of H32, which is common to all 
mutants, and ASEIADIP. The calculated ApK, contribution of 
H32 is 0.77, which is independent of partial charge set and 
does not vary significantly between the two VdW radii sets. It 
is reasonable to assume that H32 will be protonated at the 
acidic pH of the C30 pK, measurements. A change in redox 
potential of 35 mV was measured for the P34H mutation in 
thioredoxin [21], which would correspond to a ApK, of about 
0.6 if redox potential is directly related to thiolate pK, [lo]. 
Table 2 shows that the calculated ApK,‘s mostly consist of the 
positive H32 contribution plus another positive result gained 
from adding ASE and ADIP. If the range of calculated H32 
contribution is correct, then the experimental data in Table 1 
also support the suggestion of an additional positive contribu- 
tion to ApK,. 
The net positive contribution from ASE+ADIP comes from 
three genera1 sources. First, the GROMOS partial charge set 
gives a contribution of about +0.5 to ADIP from the replace- 
ment of the P31 with a non-proline residue containing the 
peptide NH group. As discussed, this effect is much smaller 
with the QUANTA/CHARMm partial charge set, and it is 
therefore not clear how large a contribution P31 makes to 
the oxidising power of DsbA. The charge disposition (com- 
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Table 1. Experimental and calculated ApK,‘s for DsbA mutants 
Mutant Experiment GROMOS QUANTA/ 
CHARMm 
derestimating experimental values. For example, comparing 
experiment and calculations with the GROMOS partial 
charge set, the following results (listed as mutantexperi- 
ment&, = 3/E, = 20) are obtained: PL - 1 .OO, 0.85, 0.49; SV 
- 0.81, 1.11, 0.43; QL - 1.17, 1.28, 0.51; LT - 1.44, 1.64, 
0.55. It is clearly important to use low Ed to provide a reason- 
able estimate of thiolate interactions in DsbA. Such discussion 
also argues against the use of simple Coulomb calculations 
based on a uniform high dielectric, in this case. Additionally, 
the effect of incorporating the I+,/& boundary in the PB solu- 
tion is seen in the ApK, contributions that arise from dielec- 
tric boundary movement in the mutants. 
sv 0.81 (0.23) 1.11 0.87 
SF 0.92 (0.23) 1.07 0.83 
PL 1 .OO (0.28) 0.85 0.84 
g 1.17 03 (0.24) 1 0.79 1.28 0.43 1.01 
TR 1.34 (0.23) 0.76 0.46 
LT 1.44 (0.21) 1.64 1.30 
PS 1.45 (0.23) 0.96 0.82 
Experimental ApK,‘s [lo], (J. Bardwell, personal communication) are 
taken relative to a wt pK, of 3.42 (0.18), and sequence of PH. Values 
in parentheses give the reported experimental error. Calculated values 
are quoted for the GROMOS and QUANTA/CHARMm partial 
charge sets. Listed amino acids are residues 3 1 and 32 that lie between 
the active site cysteines, 30 and 33. Mutants are ranked according to 
the experimental values. 
pared with non-proline) probably has some effect, but not 
more than 0.5 of a pK, unit. Second, the location of hydroxyl 
groups introduced in the mutants affects ADIP, but generally 
to a small degree since the OH-thiolate interactions are out- 
side of hydrogen-bonding range and solvent exposed. Third, 
the effect of changing the dielectric boundary is to modify 
accumulated interactions with the thiolate. This boundary al- 
teration also changes ASE, but in the opposite sense. In gen- 
eral terms, an increase in SA will decrease the (mostly) favour- 
able thiolate-partial charge interactions, whilst also 
decreasing the unfavourable self-energy penalty for charge 
burial. It is this last effect that plays a large part in the com- 
pensation of ASE and ADIP, where mutant thiolates tend to 
be more stable in self-energy terms (negative ASE), but less 
stable in partial charge interactions (positive ADIP). This is 
consistent with the listed changes in SA between wt and mu- 
tants, which are mostly positive. 
The calculations suggest that the molecular factors under- 
lying the experimental ApK,‘s are H32 removal, possibly some 
contribution from charge disposition for P31 or non-P31, rel- 
atively small contributions for introduced sidechain hydrox- 
yls, and a sizeable effect associated with dielectric boundary 
alteration, reflected in SA changes. This last term acts to 
modify the interactions which have evolved to stabilise the 
C30 thiolate, and it appears that generally a slight opening 
of the active site gives a small reduction in the stabilisation, 
and contributes to move the mutant C30 pK,‘s further away 
from wt than would H32 removal alone. The detailed ranking 
of these effects is not accurate in comparison with experiment, 
and such discrepancy again lies in the area of conformational 
and other modelling error. The contributions listed in Table 2 
suggest that mutations can have electrostatic effects where 
direct charge alteration is not involved. The energetics of di- 
electric boundary movement is significant, although there is 
some compensation between self-energy and chargecharge 
interactions. These observations are conducted at one end of 
the spectrum of SA changes in which overall pK, calculations 
operate, and give some indication of the problems associated 
with calculating the energetics of a process that involves sub- 
stantial charge burial. 
It may be expected that the DsbA C30 thiolate system will 
be a severe test for the model which uses Ed = 20 [ 151, since low 
solvent exposure places emphasis on the protein dielectric. 
With regard to the active site peptide mutants of DsbA this 
is indeed the case, with zp = 20 calculations substantially un- 
3.2. The oxidising power of DsbA 
In terms of understanding the oxidising power of DsbA, 
and how this may be further manipulated, the current study 
emphasises that the amino acids at the active site are not only 
important for what charge they present, but also for how they 
form a low dielectric region around the thiolate that intensifies 
interactions from other parts of the protein. It will be inter- 
esting to calculate ApK, for the PP mutant when the structure 
is determined experimentally. In the sense that DsbA has 
evolved to stabilise the C30 thiolate, it is not surprising that 
disruptions to the active site structure will interfere with this 
stabilisation, and give a large positive ApK, (3.3 for the PP 
mutant [lo]). An analysis of the likely conformational effect of 
the PP mutant has been made. Starting with the mainchain 
conformation common to E. coli DsbA and E. coli thioredox- 
in, a CB (P31)-CD (P32) contact distance of 3.0 A is ob- 
served. This loop, which forms the amino terminus of an IX- 
helix, can accommodate these prolines separately but must 
alter to accept the PP mutant. Model-building suggests that 
the close contact can be alleviated within a loop that main- 
tains a helical turn, and in which the largest change is an 
increase in the solvent exposure of the C30 sidechain, with 
accompanying movement of M64. This proposed conforma- 
tional change would substantially reduce the C30 thiolate sta- 
bilisation associated with the ADIP term, and would be con- 
sistent with the large experimental ApK,. Modelling also 
suggests that the equivalent change in thioredoxin would 
have a smaller effect on the C32 pK,, since ADIP is smaller 
[l 11, and since there is no residue directly equivalent to M64 
of DsbA. Indeed, the PP variant occurs in thioredoxins from 
Arabidopsis thaliana [23], without appearing to cause a large 
change in functional properties. 
Non-PP mutants are assumed to adopt homologous active 
site structures to E. coli DsbA and E. coli thioredoxin. The 
maximum ApK, for these mutants is 1.5, less than half the 
difference of 3.2 between DsbA/C30 and thioredoxinlC32 
pK,‘s. This observation is consistent with the suggestion [l l] 
Table 2. Contributions to calculated ApK,‘s for DsbA mutants 
Mutant Total % ASA H32 ASE ADIP 
sv 1.11 1.2 0.77 -0.33 0.70 
SF 1.07 2.2 0.77 -0.94 1.26 
PL 0.85 -0.4 0.77 -0.56 0.61 
g 
0.79 0.7 0.77 -0.39 0.39 
1.28 0.9 0.77 -0.26 0.79 
TR 0.76 1.7 0.77 -0.58 0.91 
LT 1.64 0.8 0.77 -0.42 1.28 
PS 0.96 0.4 0.77 -0.12 0.32 
All columns are listed in pK, units, except for that labelled % ASA, 
which gives the fractional solvent accessibility [22]. 
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that the sum of many interactions (rather than just those 
within the disulphide sequence) provides the oxidising power 
of DsbA in comparison with thioredoxin. A hypothetical 
DsbA mutant with the thioredoxin sequence of GP gives a 
calculated ApK, of 1.6 (using the GROMOS partial charge 
set), again indicating the presence of DsbA/thioredoxin differ- 
ences in the addition to the active site sequences. An nmr 
study of E. coli thioredoxin has been used to suggest that 
the low C32 pK, is largely due to the close approach of the 
C35 thiol [24]. The current discussion emphasises that it is 
equally important to look outside of the CXXC sequences 
to account for pK, and redox effects in this family of proteins. 
The agreement between experiment and computation, dem- 
onstrated in this article for the sign and overall size of ApK,‘s, 
gives confidence that the model is identifying the molecular 
detail that determines thiolate pK, and oxidising power. Mu- 
tant calculations emphasise the effect of H32 (up to 0.8 pK, 
units), and raise the possibility of a contribution of up to 0.5 
pK, unit for P31/non-P31, although the size of this effect 
depends on the partial charge set. Variation of ApK, across 
mutants which have common contributions from these two 
sources is partly due to sidechain hydroxyl interactions, and 
more significantly to changes in SA at the active site, that 
alter the balance of charge interactions. It has been suggested 
[ 1 l] that around half of the DsbA/thioredoxin difference arises 
from two identifiable sources outside of the active site peptide. 
These are the DsbA 497 sidechain, and the mainchain region 
3743 in DsbA. Residue 497 lies in the extra domain, relative 
to thioredoxin. The overall effect of the extra domain is diffi- 
cult to assess since it depends on the detail of the link between 
the extra module and the thioredoxin-like domain, around 
residues 62-64. The mainchain segment 3743 in DsbA is 
associated with an a-helical insert that is absent in thioredox- 
in. 
Proteins within the thioredoxin family, including protein 
disulphide isomerase (PDI) and glutaredoxin, are unlikely to 
use exclusively those features identified here to modify redox 
potential. It has been shown that redox potential alteration is 
directly related to changes in thiolate pK, [lo], and electro- 
static calculations suggest that such changes incorporate ef- 
fects inside and outside of the active site. Whilst some features 
are repeated, such as an equivalent histidine to H32 (DsbA) in 
PDI, it can be expected that evolution will find several routes 
to pK, modification. However, it is likely that all systems that 
act to increase oxidising power by reducing the thiolate pK, 
substantially below that of free cysteine, will do so by charge 
burial. This is a key factor in intensifying interactions between 
the negatively-charged thiolate and amino acids around the 
active site. Given the extent of these interactions, it is unlikely 
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that simply writing down the active site sequence will be suffi- 
cient to describe in full the oxidising properties of proteins 
within the thioredoxin family. 
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